Saba Capitalome & Opportunities Fund (Saba Capitalome & Opportunities Fund) Asset Impairment Charge

: $0.00 Mil (TTM As of Oct. 2023)

View and export this data going back to . Start your Free Trial

Saba Capitalome & Opportunities Fund's Asset Impairment Charge for the six months ended in Oct. 2023 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Oct. 2023 was $0.00 Mil.

Saba Capitalome & Opportunities Fund Asset Impairment Charge Historical Data

The historical data trend for Saba Capitalome & Opportunities Fund's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saba Capitalome & Opportunities Fund Annual Data

Trend

Feb18

Feb19

Feb20

Feb21

Oct22

Oct23

Asset Impairment Charge

Get a 7-Day Free Trial

Saba Capitalome & Opportunities Fund Semi-Annual Data
	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Apr22	Oct22	Apr23	Oct23
Asset Impairment Charge	Get a 7-Day Free Trial								-	-	-	-	-

Saba Capitalome & Opportunities Fund Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Oct. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Saba Capitalome & Opportunities Fund Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Saba Capitalome & Opportunities Fund's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Saba Capitalome & Opportunities Fund (Saba Capitalome & Opportunities Fund) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Saba Capital Income & Opportunities Fund (NYSE:BRW) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

405 Lexington Avenue, 58th Floor, New York, NY, USA, 10174

Website

https://www.sabacef.com

Saba Capital Income & Opportunities Fund t is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

Executives

Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Troy M Statczar	officer: Principle Financial Officer	3 CANAL PLAZA, PORTLAND ME 04101
Nitin Sapru	officer: Vice President	405 LEXINGTON AVE, 58TH FLOOR, NEW YORK NY 10174
Michael D'angelo	officer: Secretary	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Patrick J Keniston	officer: Chief Compliance Officer	FORESIDE COMPLIANCE SERVICES, LLC, THREE CANAL PLAZA, SUITE 100, PORTLAND ME 04101
Pierre Weinstein	officer: Chief Executive Officer	C/O SABA CAPITAL MANAGEMENT L.P., 405 LEXINGTON AVENUE, 5TH FLOOR, NEW YORK NY 10174
Christopher P Sullivan	other: Former Trustee	27 LEE TERRACE, SHORT HILLS NJ 07078
Thomas Bumbolow	director	C/O VOYA PRIME RATE TRUST, 7337 EAST DOUBLETREE RANCH RD., STE 100, SCOTTSDALE AZ 85258
Neal Neilinger	director	126 CLAPBOARD RIDGE ROAD, GREENWICH CT 06830
Charles I Clarvit	director	TWO INTERNATIONAL PLACE, BOSTON MA 02110
Kieran Goodwin	director	925 PARK AVENUE 11B, NEW YORK NY 10028
Ketu Desai	director	999 RIVERVIEW DR, SUITE 201, TOTOWA NJ 07512
Karen Caldwell	director	10125 SOUTH BELL AVENUE, CHICAGO IL 60643
Aditya Bindal	director	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Andrew Kellerman	director	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174